Intestinal cancer in spite of screening

NewsGuard 100/100 Score

Only every second patient with colorectal carcinoma had taken part in an early detection program within the last ten years.

This is the result, at least for a group of 212 colorectal cancer patients whose screening behavior is examined in the current edition of Deutsches Ärzteblatt International ( Dtsch Arztebl Int 2009; 106[12]: 195) by Konrad Schoppmeyer and his colleagues from Leipzig University Hospital.

The authors have performed a retrospective analysis of the data on screening examinations for the ten years before the diagnosis of colorectal cancer.

In 83% of patients, the colorectal carcinoma was discovered after symptoms had developed. In 17% of patients, the diagnosis was made during screening. In the 10 years before the diagnosis, 51% of the colorectal cancer patients had used screening tests for early recognition. The most frequent of these was the test for fecal occult blood—although this was mostly not in accordance with the guidelines. 25 patients had undergone colonoscopy, 20 of these within the five years before diagnosis.

The most frequent reason that screening tests were not used was that patients were unaware of what was available. Schoppmeyer et al. therefore advocate that doctors should provide their patients with more detailed advice. Moreover, procedures should be in accordance with the guidelines.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New microfluidic device improves the separation of tumor cells and clusters from malignant effusions